ecrin-mdr-crcClinical2007Metastatic Colorectal CancerMetastatic colorectal cancerMetastatic Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2522328Austria8XelodaTarcevaAvastinECRIN MDRCompletedfalsePhase III study of an optimized chemotherapy + Avastin strategy +/- Tarceva in metastatic colorectal cancer.Primary objectives: To show superiority in Progression Free Survival (PFS) from the date of randomization with Avastin plusTarceva compared to Avastin alone.2007-08-1525223282007-002797-56